Monday, November 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

FDA scientists opposed Trump administration’s move to ease peptide access

Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency

DO
By Daniel Okafor · Regulatory Correspondent
Oct 28 16:26 ETSource: The Guardian

From the source

FDA scientists opposed Trump administration’s move to ease peptide access

Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientists

Read at theguardian.com
PeptiPrescribed peptides from $99/moSee all →